E
Moderna, Inc. MRNA
$32.87 -$0.77-2.29% NASDAQ
Recommendation
Prev Close
$33.64
Volume
7,251,687
Avg Vol (90D)
10,723,220
Market Cap
$13.01B
Dividend & Yield
--
52-Week Range
$23.15 - $129.39
P/E (TTM)
--
EPS (TTM)
-$8.74
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Moderna Stock Looks Ripe for a Short Squeeze
5/22/2025 - MarketBeat
JPMorgan reveals 9 stocks with major problems
7/14/2025 - TheStreet.com
Why Moderna (MRNA) Stock Is Falling Today
7/14/2025 - StockStory Articles
Best Biotech Stocks Worth Watching - July 14th
7/14/2025 - MarketBeat
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges
7/14/2025 - GuruFocus
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults
7/14/2025 - Zacks Investment Research
Moderna (MRNA) Remains Most Shorted Stock in Health Care Sector
7/14/2025 - GuruFocus
What to Expect From Moderna's Next Quarterly Earnings Report
7/14/2025 - Yahoo! Finance: News
Delta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?
7/13/2025 - Benzinga
JPMorgan Says to Short Tesla (TSLA), Moderna (MRNA), and 7 Other Stocks in 2025
7/13/2025 - TipRanks Financial Blog
Notable healthcare headlines for the week: Trump's tariff threat, Merck, UnitedHealth and Moderna in focus
7/13/2025 - SeekingAlpha.com: All News
Bank of New York Mellon Corp Acquires 34,034 Shares of Moderna, Inc. (NASDAQ:MRNA)
7/13/2025 - MarketBeat
Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes
7/12/2025 - Simply Wall St
DekaBank Deutsche Girozentrale Purchases 1,473 Shares of Moderna, Inc. (NASDAQ:MRNA)
7/12/2025 - Ticker Report
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
7/11/2025 - Zacks Investment Research
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
7/11/2025 - StockStory Articles
What's Driving the Market Sentiment Around Moderna?
7/11/2025 - Benzinga
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
7/11/2025 - Zacks Investment Research
SPDR S&P Biotech ETF Experiences Big Outflow
7/11/2025 - ETF Channel
This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now
7/11/2025 - 24/7 Wall St.
Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
7/11/2025 - Zacks Investment Research
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025
7/11/2025 - ACCESS Newswire
2 Stocks Under $50 on Our Watchlist and 1 to Ignore
7/11/2025 - StockStory Articles
FDA Approves Moderna's COVID-19 Vaccine For Some Children
7/10/2025 - Zero Hedge
MarketBeat Week in Review – 03/10 - 03/14
3/15/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$3.18B
EBITDA (TTM)
-$3.54B
EBIT (TTM)
-$3.73B
Net Income (TTM)
-$3.36B
Balance Sheet
Total Assets (Q)
$12.70B
Total Debt (Q)
$745.00M
Total Liabilities (Q)
$2.64B
Book Value Per Share (Q)
$26.01
Cash Flow
Cash from Operations (TTM)
-$3.05B
Cash from Investing (TTM)
$2.56B
Cash from Financing (TTM)
$46.00M
Net Change in Cash (TTM)
-$445.00M
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
1.32
7-Day Total Return
8.55%
30-Day Total Return
22.06%
60-Day Total Return
25.27%
90-Day Total Return
8.23%
Year to Date Total Return
-21.74%
1-Year Total Return
-72.94%
2-Year Total Return
-73.90%
3-Year Total Return
-81.03%
5-Year Total Return
-54.21%
52-week Low
Apr 07, 2025 - $23.15
52-week High
Jul 12, 2024 - $129.39
Valuation
Market Cap
$13.01B - Large Cap
Enterprise Value
$5.36B
Price/Sales (TTM)
4.09
Price/Book (Q)
1.29
Dividends and Shares
Shares Outstanding
386.00
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.modernatx.com
Phone Number
617 714 6500
Address
325 Binney Street
Cambridge, MA 02142
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID... more
NASDAQ 07/14/2025 4:00PM Eastern Quotes delayed